Mechanisms of Enhancer-mediated Hormonal Control of Vitamin D Receptor Gene Expression in Target Cells.
The biological actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the vitamin D receptor (VDR), whose expression in bone cells is regulated positively by 1,25(OH)2D3, retinoic acid, and parathyroid hormone through both intergenic and intronic enhancers. In this report, we used ChIP-sequencing analysis to confirm the presence of these Vdr gene enhancers in mesenchyme-derived bone cells and to describe the epigenetic histone landscape that spans the Vdr locus. Using bacterial artificial chromosome-minigene stable cell lines, CRISPR/Cas9 enhancer-deleted daughter cell lines, transient transfection/mutagenesis analyses, and transgenic mice, we confirmed the functionality of these bone cell enhancers in vivo as well as in vitro. We also identified VDR-binding sites across the Vdr gene locus in kidney and intestine using ChIP-sequencing analysis, revealing that only one of the bone cell-type enhancers bound VDR in kidney tissue, and none were occupied by the VDR in the intestine, consistent with weak or absent regulation by the 1,25(OH)2D3 hormone in these tissues, respectively. However, a number of additional sites of VDR binding unique to either kidney or intestine were present further upstream of the Vdr gene, suggesting the potential for alternative regulatory loci. Importantly, virtually all of these regions retained histone signatures consistent with those of enhancers and exhibited unique DNase I hypersensitivity profiles that reflected the potential for chromatin access. These studies define mechanisms associated with hormonal regulation of the Vdr and hint at the differential nature of VDR binding activity at the Vdr gene in different primary target tissues in vivo.
From the Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706 and.
Seong Min
SM
Lee
From the Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706 and.
Mark B
MB
Meyer
From the Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706 and.
Nancy A
NA
Benkusky
the Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205.
Charles A
CA
O'Brien
From the Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706 and pike@biochem.wisc.edu.
J Wesley
JW
Pike
D000818:Animals; D002117:Calcitriol / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D004742:Enhancer Elements, Genetic / Q000502:physiology*; D005786:Gene Expression Regulation / Q000502:physiology*; D006728:Hormones / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008822:Mice, Transgenic; D018167:Receptors, Calcitriol / Q000235:genetics / Q000378:metabolism*
D006728:Hormones; D018167:Receptors, Calcitriol; D002117:Calcitriol
1,25(OH)2D3 regulated Vdr gene expression; ChIP-sequencing (ChIP-seq); VDR regulated enhancers; autoregulation; gene transcription; transcription enhancer; transcription regulation; vitamin D